about
Triflusal for preventing serious vascular events in people at high riskIn vitro cytotoxicity and mitochondrial toxicity of tenofovir alone and in combination with other antiretrovirals in human renal proximal tubule cellsRandomized comparative trial of triflusal and aspirin following acute myocardial infarctionThe rapid anticoagulation prevents ischemic damage study in acute stroke--final results from the writing committeeComparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trialHigh-flow oxygen therapy in acute respiratory failureCocoa, hazelnuts, sterols and soluble fiber cream reduces lipids and inflammation biomarkers in hypertensive patients: a randomized controlled trialHaemodiafiltration and mortality in end-stage kidney disease patients: a pooled individual participant data analysis from four randomized controlled trials.Genetically-defined deficiency of mannose-binding lectin is associated with protection after experimental stroke in mice and outcome in human strokeRelationship between intraoperative regional cerebral oxygen saturation trends and cognitive decline after total knee replacement: a post-hoc analysis.Multicentre hospital drug utilization study on the prophylaxis of venous thromboembolism. The Venous Thromboembolism Study Group of the Spanish Society of Clinical PharmacologyAssociation of thymidylate synthase polymorphisms with acute pancreatitis and/or peripheral neuropathy in HIV-infected patients on stavudine-based therapyEffect of two doses of a mixture of soluble fibres on body weight and metabolic variables in overweight or obese patients: a randomised trial.Allergy to human seminal fluid: cross-reactivity with dog dander.Association of thymidylate synthase gene polymorphisms with stavudine triphosphate intracellular levels and lipodystrophy.Polymorphisms of Pyrimidine Pathway Enzymes Encoding Genes and HLA-B*40∶01 Carriage in Stavudine-Associated Lipodystrophy in HIV-Infected Patients.Is the new Mayo Clinic Quadratic equation useful for the estimation of glomerular filtration rate in type 2 diabetic patients?Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular studyEffects of free leucine supplementation and resistance training on muscle strength and functional status in older adults: a randomized controlled trial.Evaluation of dose reduction versus standard dosing for maintenance of remission in patients with spondyloarthritis and clinical remission with anti-TNF (REDES-TNF): study protocol for a randomized controlled trialAssociation of ITPA gene polymorphisms and the risk of ribavirin-induced anemia in HIV/hepatitis C virus (HCV)-coinfected patients receiving HCV combination therapy.Evaluation of two treatment strategies for the prevention of preterm birth in women identified as at risk by ultrasound (PESAPRO Trial): study protocol for a randomized controlled trial.Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial.High-efficiency postdilution online hemodiafiltration reduces all-cause mortality in hemodialysis patients.Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancerEffects of docosahexanoic acid on metabolic and fat parameters in HIV-infected patients on cART: A randomized, double-blind, placebo-controlled study.Ambulatory adaptation to noninvasive ventilation in restrictive pulmonary disease: a randomized trial with cost assessment.A randomized clinical trial of oral versus intravenous methylprednisolone for relapse of MS.Fat tissue measurements by dual-energy x-ray absorptiometry: cross-calibration of 3 different fan-beam instruments.Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?The importance of considering competing treatment affecting prognosis in the evaluation of therapy in trials: the example of renal transplantation in hemodialysis trials.Objective response by mRECIST as a predictor and potential surrogate end-point of overall survival in advanced HCC.Timing Affects Measurement of Portal Pressure Gradient After Placement of Transjugular Intrahepatic Portosystemic Shunts in Patients With Portal Hypertension.Mortality reduction by post-dilution online-haemodiafiltration: a cause-specific analysis.[Usefulness of a multidimensional self-administered questionnaire for the clinical management of a pain treatment unit].A truncated form of IKKα is responsible for specific nuclear IKK activity in colorectal cancer.Towards improved migraine management: Determining potential trigger factors in individual patients.Double-blind, randomized, placebo-controlled Phase I Clinical Trial of the therapeutical antituberculous vaccine RUTI.Usefulness of MDCT to Differentiate Between Renal Cell Carcinoma and Oncocytoma: Development of a Predictive Model.
P50
Q24246399-5B54960E-000F-4944-8263-4667BA0F068DQ24674939-1EDCAA3D-C617-4BE7-90CD-03593728A02DQ28162614-AE8634A7-5AB9-45FA-9EF7-A27E4AAD82FCQ28176189-DC157F9C-6883-49BC-B08C-CB87BAC6F1ECQ28195452-DC947C16-9FC7-4656-952D-123EF6F203C7Q28280261-D006595A-3F8B-4142-BCCB-331942A72089Q28731712-B3B5F07C-A200-447B-9754-A57C8C20B5A7Q31009800-FD7A8F4F-869D-4D8A-A600-584258919D3CQ33530136-3EC04730-E69D-4718-A327-7DD8B8569432Q33943523-5B8AB0B7-EA7F-49A7-82CB-C01925EF8A8FQ34346122-B23B9371-01A0-40EB-A711-F0632CC134D7Q34612023-CF3E5C93-B4F8-4DB5-9DC2-87862AFC2D65Q34716782-89E64B79-3F6A-48A6-A488-2903BBF16BD4Q34722325-54A9EABF-3569-47E9-9365-1198E02901FEQ34737674-98EE572E-C288-42A7-A32A-49A0FC27186DQ34806335-8562DC0C-F4AB-448B-9375-386BDF22341EQ34845577-1C55C5FD-CB18-4A5C-A4DD-1FEFEADDE9ADQ34994544-22D6FEBF-4369-4C90-A44A-F8D80CC9BE4AQ35106654-6C6A3C44-8C4E-4777-A80E-366A7C055887Q35493238-91D39AB2-B2A8-46B2-8AEB-96BEEFB0A9C9Q35986462-D1A65723-FDFB-4EBC-B69B-2DE76D84E796Q36018931-7A4BB1FC-FFC8-470D-B572-57DBB5106DB4Q36095536-90C24F81-8838-4784-B228-8D358BFD7A12Q36459311-35728676-3D56-4FC9-A436-F896B1E49021Q36638382-12989296-76CD-421F-BF2A-646CD1271727Q37158989-F59BC90B-E96F-4A0A-A862-69464D5508D4Q38374994-DF45091D-773F-4B28-BF12-4F46BC64C824Q38430142-CF812876-8932-4F8A-8E8B-5BE56217019FQ38442625-B185CAC0-75AE-44EB-871E-695F16EDA0DCQ38461618-BB4EDB6E-9A0F-424C-9EE6-CA38C6540D6AQ38847651-5ECB28A8-F88B-4244-A982-FFED8E67DC95Q38878802-72603E87-346B-486F-BCCE-11DB078B3616Q38993647-C1C184F4-6FA9-49FA-A2AD-8BA5F9D0918FQ38994735-329E9B29-3B04-4248-B9BB-7A5DAE944AF0Q39063242-CB101A48-F938-4C3E-A192-34C8CE4A74F4Q39204046-547D3D4A-1C77-40DE-9882-101C45C5FC8DQ39264872-F140B120-2219-4FDF-B105-3F7930B7F825Q39766328-A73E4C55-B329-4915-AD7A-3B3F1D4B85F6Q39935921-A64EF2A1-6C70-44E0-9117-C69AD994CEEFQ39969015-824F2AD1-6B69-42CB-878F-43A69A214B2A
P50
description
hulumtues
@sq
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Ferran Torres
@ast
Ferran Torres
@en
Ferran Torres
@es
Ferran Torres
@nl
Ferran Torres
@sl
type
label
Ferran Torres
@ast
Ferran Torres
@en
Ferran Torres
@es
Ferran Torres
@nl
Ferran Torres
@sl
prefLabel
Ferran Torres
@ast
Ferran Torres
@en
Ferran Torres
@es
Ferran Torres
@nl
Ferran Torres
@sl
P214
P1053
D-1296-2011
P106
P1153
7102336718
P21
P214
P31
P3829
P496
0000-0002-7355-7913
P569
2000-01-01T00:00:00Z
P734
P735
P7859
viaf-311585284